Avenir Wellness Solutions IncOTC Pink - Limited Information:CURR
- LAST PRICE0.1292
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.1256 / 0.1292
- Day Range
- 52 Week Range
- Volume3,245
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CURR |
|---|---|---|
| 09:32 ET | 115 | 0.1256 |
| 09:48 ET | 1000 | 0.1328 |
| 10:48 ET | 1300 | 0.126 |
| 01:57 ET | 790 | 0.1292 |
May 17, 2023
Avenir Wellness Solutions Update to Stockholders, from 6:00AM ET on Wednesday May 17, 2023 by Accesswire
6:00AM ET on Wednesday May 17, 2023 by Accesswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Avenir Wellness Solutions Inc | 9.7M | -0.5x | --- |
FDCTECH Inc | 3.8M | -2.2x | --- |
Globaltech Holdings Inc | 16.2M | 0.0x | --- |
Flexiinternational Software Inc | 3.6M | 6.1x | --- |
KYN Capital Group Inc | 2.4M | 0.0x | --- |
Alliance Media Holdings Inc | 8.8K | 0.0x | --- |
Company Information
Avenir Wellness Solutions, Inc., formerly CURE Pharmaceutical Holding Corp., is a wellness platform technology company that develops wellness, nutraceutical, and topical delivery systems. The Company's technology offers a range of immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a range of active ingredients. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged in the wellness and beauty sectors utilizing technology and products that use science-backed formulations. It sells over 25 products under the brand names Seratopical, Seratopical Revolution, SeraLabs, and Nutri-Strips. Its Nutri-Strips brand offers shelf-stable and discreet oral dissolving films. Its Seratopical brand offers advanced formulation infused with cannabidiol (CBD) to help consumers look years younger. Sera Labs products are sold direct to consumers, as well as to national drug, grocery chains, and mass retailers.
Contact Information
- Headquarters
- 5805 Sepulveda Blvd., Suite 801SHERMAN OAKS, CA, United States 91411
- Phone
- 424-273-8675
- Fax
- 302-655-5049
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.7M |
|---|---|
Revenue (TTM) | $5.6M |
Shares Outstanding | 77.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.55 |
EPS | $-0.25 |
Book Value | $0.24 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -228.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
